Steven Chetham
Gastroenterology · Longmont, CONPI 1316962376
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 423 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 37.6% of the total. Reporting peaked in 2021 at $1,692 and has fallen 98.6% since, to $23 in 2025.
Across 423 payments — averaging $15.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Takeda Pharmaceuticals U.S.A., Inc.$788
- Johnson & Johnson$484
- QOL Medical, LLC$366
- Gilead$342
- plus $1K from 17 others
What the payments were for
- Food & beverage$6,67899%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 176 | $2,531 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 79 | $1,075 |
| Takeda Pharmaceuticals U.S.A., Inc. | 44 | $788 |
| Johnson & Johnson | 26 | $484 |
| QOL Medical, LLC | 21 | $366 |
| Gilead | 19 | $342 |
| Pfizer | 9 | $248 |
| Nestle Healthcare Nutrition Inc. | 8 | $142 |
| Regeneron Healthcare Solutions, Inc. | 4 | $112 |
| Intercept Pharmaceuticals, Inc. | 7 | $111 |
| Sanofi | 5 | $99 |
| Bristol Myers Squibb | 5 | $87 |
| Merck | 5 | $73 |
| Alfasigma USA, Inc. | 2 | $42 |
| UCB, Inc. | 2 | $38 |
| Organon | 2 | $35 |
| Ferring Pharmaceuticals Inc. | 2 | $30 |
| Shionogi Inc | 2 | $30 |
| Lilly USA, LLC | 1 | $27 |
| Fresenius Kabi USA, LLC | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $17 |
| Amgen | 1 | $17 |
| Braintree Laboratories, Inc. | 1 | $13 |
How this compares
$6,725 in reported general payments places this provider in the 75th percentile of 304 gastroenterology providers in Colorado.
Other gastroenterology in Longmont
- Scot LeweyLongmont$15K
- Simranjit BediLongmont$12K
- Tamas OtrokLongmont$11K
- David GatofLongmont$11K
- Peter McNallyFt Carson$1.1M
- Douglas AdlerColorado Springs$910K
- Marcelo KugelmasEnglewood$660K
- Mary Ann HuangDenver$408K
- Gareth WeinerThornton$382K
- Matthew NicholsLone Tree$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.